n-succinimidyl 3-iodobenzoate has been researched along with Glioblastoma in 1 studies
*Glioblastoma: A malignant form of astrocytoma histologically characterized by pleomorphism of cells, nuclear atypia, microhemorrhage, and necrosis. They may arise in any region of the central nervous system, with a predilection for the cerebral hemispheres, basal ganglia, and commissural pathways. Clinical presentation most frequently occurs in the fifth or sixth decade of life with focal neurologic signs or seizures. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Affleck, DJ; Choi, J; McDougald, D; Vaidyanathan, G; Welsh, PC; White, BJ; Zalutsky, MR; Zhao, XG | 1 |
1 other study(ies) available for n-succinimidyl 3-iodobenzoate and Glioblastoma
| Article | Year |
|---|---|
SIB-DOTA: a trifunctional prosthetic group potentially amenable for multi-modal labeling that enhances tumor uptake of internalizing monoclonal antibodies.
Topics: Animals; Antibodies, Monoclonal; Cell Line, Tumor; ErbB Receptors; Glioblastoma; Heterocyclic Compounds, 1-Ring; Humans; Immunotoxins; Iodine Radioisotopes; Iodobenzoates; Isotope Labeling; Mice; Mice, Inbred BALB C; Organometallic Compounds; Radiopharmaceuticals; Tin; Tissue Distribution | 2012 |